If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
Proceedings Series - International Atomic Energy Agency
English STI/PUB/1913 | 978-92-0-117720-9
34 pages | € 32.00 | Date published: 2020The use of radiopharmaceuticals is an important tool not only for management of diseases and dysfunctions, but also for better understanding human diseases and developing effective treatment options, such as in the case of neurology. In this context, there is concern of continuous, impressive progress in nuclear medicine which is linked to the development of new radiopharmaceuticals and efficient production of relevant radioisotopes. These proceedings highlight the main findings and developments discussed during the International Symposium on Trends in Radiopharmaceuticals. They cover the key issues and advances in the field of radiopharmaceuticals from development, production, and use of diagnostic, therapeutic, and theranostic radioisotopes and radiopharmaceuticals, as well as regulatory and licensing issues related to their production. Additional topics addressed were education, certification and training methodologies. A supplementary file contains the detailed programme of the symposium and the abstracts of all oral and poster presentations.
More Information on reusing IAEA copyright material.
Orders and requests for information may also be addressed to:
Publishing Section
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria
Tel.: +43 1 2600 22529, +43 1 2600 22530
Email: sales.publications@iaea.org
